| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377678A2 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377596A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 01/07/2004 | EP1377587A1 Protein phosphate inhibitors |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377320A2 Polynucleotide binding complexes comprising sterols and saponins |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377309A1 Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof |
| 01/07/2004 | EP1377301A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 01/07/2004 | EP1377298A2 Combined method for treating hormono-dependent disorders |
| 01/07/2004 | EP1377297A2 Degradation-resistant glucocorticosteroid formulations |
| 01/07/2004 | EP1377294A2 Use of neuroactive substances for the treatment of parkinsons disease and pharmaceutical combination |
| 01/07/2004 | EP1377293A1 Aryl and biaryl piperidines used as mch antagonists |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377289A2 Heterocyclic compounds for therapeutic use |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377285A1 Pharmaceutical composition comprising ibuprofen and prochlorperazine |
| 01/07/2004 | EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 01/07/2004 | EP1377278A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377253A1 Methods of preventing uvb-induced skin damage |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1377164A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 01/07/2004 | EP1103243B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives for the treatment of troubles mediated by an excess of substance p |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0935457B1 Preparation for the transport of an active substance across barriers |
| 01/07/2004 | EP0724436B1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 01/07/2004 | CN1466680A Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 01/07/2004 | CN1466458A Use of arginine in the preparation of a medicament for the prevention and treatment of the side effcts associated with the intravenous administration |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract |
| 01/07/2004 | CN1466452A Composition for the transdermal delivery of fentanyl |
| 01/07/2004 | CN1465338A Skin activating composition for external used anti-aging preparation |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133433C Nucleoside analogs in combination therapy of herpes simplex infections |
| 01/07/2004 | CN1133426C Novel stable preparation use paracetamol as base and method for preparing same |
| 01/07/2004 | CN1133422C Topical application of combination of benzoyl peroxide and second active ingredient |
| 01/06/2004 | US6675136 Global method for mapping property spaces |
| 01/06/2004 | US6675105 Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
| 01/06/2004 | US6673819 Compounds useful as antibacterial agents |
| 01/06/2004 | US6673815 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/06/2004 | US6673812 Administering effective amount of compound having rho kinase inhibitory activity |
| 01/06/2004 | US6673809 Tricyclic compounds as MRP1-inhibitors |
| 01/06/2004 | US6673807 Administering compound possessing inhibitory activity on production of nitric oxide and tricyclic macrolide or salt, solvate or hydrate thereof to increase graft survival time in transplantation subject |
| 01/06/2004 | US6673791 Non-nucleoside reverse transcriptase inhibitors |
| 01/06/2004 | US6673777 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 01/06/2004 | US6673775 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673558 Drug compositions to prevent desensitization of cellular receptors |
| 01/06/2004 | US6673555 Methods of using SCAP antagonists |
| 01/06/2004 | US6673554 Protein localization assays for toxicity and antidotes thereto |
| 01/06/2004 | US6673374 Pharmaceutical compositions and methods for managing skin conditions |
| 01/06/2004 | US6673365 Administering hooc-ch2-(r)-cgl-aze-pab where cgl is cyclohexylglycine, aze is azetidine-2-carboxylic acid, and pab is 1-amidino-4-aminomethylbenzene |
| 01/06/2004 | US6673341 Inhibiting transforming growth factor (tgf-beta) mediated angiogenesis, thereby inhibiting the proliferative disease in vertebrate |
| 01/06/2004 | US6673337 Compositions containing alpha-2-adrenergic agonist components |
| 01/06/2004 | US6673217 E-water machine |
| 01/06/2004 | US6673039 Compositions, kits, methods, and apparatus for transvascular delivery of a composition to an extravascular tissue of a mammal |
| 01/06/2004 | CA2309717C Treatment of scar tissue using lipoic acid |
| 01/06/2004 | CA2247063C Treatment of macular edema |
| 01/06/2004 | CA2232008C Use of epinastine for the treatment of pain |
| 01/06/2004 | CA2106895C Combating fish parasites |
| 01/06/2004 | CA2086681C Growth promoting agent derived from milk |
| 01/02/2004 | EP1375519A2 Method for affecting cellular function using antibodies |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1374908A2 Polymer-drug conjugates comprising hydrazide linkers |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374901A1 Graft rejection suppressors |
| 01/02/2004 | EP1374900A1 Remedies for infant chronic arthritis-relating diseases |
| 01/02/2004 | EP1374898A1 Remedies for nerve damages |
| 01/02/2004 | EP1374890A2 Thrombopoietin compositions for increasing circulating platelets |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1374872A1 Pharmaceutical preparations comprising a combination of at least one representative of antibiotics and one of antiphlogistics, process for manufacturing, and use thereof |
| 01/02/2004 | EP1374870A1 Medication for the treatment or prevention of migraine |
| 01/02/2004 | EP1374862A2 Use of a substance influencing the degree of phosphorylation of BAD for the treatment of atherosclerosis |
| 01/02/2004 | EP1374861A1 External preparations for treating dermatoses |
| 01/02/2004 | EP1374856A1 Oily thixotropic nasal spray |
| 01/02/2004 | EP1374854A1 Delayed release pharmaceutical composition, method of production and use of said composition |
| 01/02/2004 | EP1374853A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374852A1 Cosmetic and/or dermatological Composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374851A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374850A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374849A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373893A2 Phosphoprotein target for insulin and its antagonists |
| 01/02/2004 | EP1373888A2 Method for screening for progesterone receptor isoform-specific ligands |
| 01/02/2004 | EP1373609A1 Method for forming hardened tubes and sheets |
| 01/02/2004 | EP1373559A2 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene |
| 01/02/2004 | EP1373554A2 Modulators of bruton's tyronsine kinase, their identification and use |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |